Top Markets
#1 Gravity Gravity +75.10%
#2 Galxe Galxe +57.82%
#3 TENDIES TENDIES +36.20%
#4 Railgun Railgun +36.15%
#5 Geodnet Geodnet +24.60%
#6 Fake World Assets Fake World Assets +23.71%
#7 Akedo Akedo +22.61%
#8 Injective Injective +16.93%
#9 Kinetiq Kinetiq +16.68%
#10 Collector Crypt Collector Crypt +16.50%
Coin of the day
Gravity Gravity
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Roche Holding AG Roche Holding AG

Roche Holding AG

RO
Rangering i aksjer #36
Roche Holding AG is a global healthcare enterprise with dual focuses:... Roche Holding AG is a global healthcare enterprise with dual focuses: pharmaceuticals and diagnostics. The company maintains a significant presence in numerous countries, including its home base in Switzerland, alongside Germany, the United States, Austria, the Netherlands, the United Kingdom, France, Belgium, and various other international markets. Its pharmaceutical segment develops and supplies treatments for a wide spectrum of medical conditions, encompassing oncology, neuroscience, infectious diseases, immunology, cardiovascular and metabolic disorders, ophthalmology, and respiratory ailments, as well as specific therapies for anemia, dermatology, hemophilia, inflammatory and autoimmune conditions, and transplant patients. On the diagnostic front, Roche provides in vitro tests designed to identify various diseases like cancer, diabetes, COVID-19, hepatitis, and human papillomavirus, in addition to supplying crucial diagnostic instruments and reagents. The company was founded in Basel, Switzerland, in 1896.
Aksjekurs
$483.81
Markedsverdi
$379.28B
Endring (1 dag)
0.92%
Endring (1 år)
46.65%
Land
CH
Handel Roche Holding AG (RO)

Kategori

Healthcare
P/S-forhold for Roche Holding AG (RO)
P/S-forhold per September 2026 TTM: 4.17
Ifølge Roche Holding AG sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/S-forhold (TTM) 4.17. Ved slutten av 2026 hadde selskapet et P/S-forhold på 0.
P/S-historikk for Roche Holding AG fra 2026 til 2026
P/S-forhold ved hvert års slutt
År P/S-forhold Endre
Ikke nok data for de angitte datoene.
P/S-forhold for lignende selskaper eller konkurrenter
Selskap P/S-forhold Forskjell i P/S-forhold Land
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
13.45 222.49%
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
6.55 57.15%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
7.18 72.19%
US
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
5.39 29.18%
US
Novartis AG Novartis AG
Novartis AG
NOVN.SW
5.52 32.37%
CH